Skip to main content
Back to news homepage

RCOG statement on hormone therapy use for menopause

News 13 September 2017

Hormone therapy use up to 7 years among postmenopausal women was not associated with an increased risk of death from cardiovascular, cancer, or all causes for nearly 2 decades of follow up, a new analysis shows.The results from the Women's Health Initiative trial are published in JAMA.

Commenting in response, Dr Heather Currie, spokespeople for the Royal College of Obstetricians and Gynaecologists (RCOG) and British Menopause Society (BMS), says: 

“We welcome these encouraging results of long term follow up of the Women’s Health Intiaitive trial which show that hormone therapy use in women who experienced menopause was not associated with an increased risk of all-cause, cardiovascular or cancer death. The question around the possibility of decreased mortality for women who start hormone therapy within 10 years of the menopause is not addressed by this report but is gaining strength from other evidence . These findings should be helpful to both women and doctors, especially when considering whether to start hormone therapy. 

“Even though not every woman requires hormone therapy, they should have accurate information about menopause and treatment options. Hormone therapy can be a safe and effective treatment for menopausal symptoms, particularly with the management of hot flushes. For each woman, however, the risks and benefits are different, depending on her medical history and her symptoms.

“If a woman is experiencing menopausal symptoms that are having an impact upon her daily life, we strongly encourage her to speak to a GP. We would like to reassure women that treatment and support is available.”

[Ends]

Note to Editors 

The RCOG and BMS have collaborated to provide women with correct information about HRT to make a properly informed decision about whether or not to take up treatment. In 2016, the BMS and Women’s Health Concern published updated recommendations on HRT inmenopausal women, while the RCOG launched an information hub about menopause and women’s health later in life. 

NICE’s guideline on Menopause: diagnosis and management has also significantly helped both women and clinicians in understanding the evidence behind the advice we provide.

About the RCOG
The Royal College of Obstetricians and Gynaecologists is a medical charity that champions the provision of high quality women’s healthcare in the UK and beyond. It is dedicated to encouraging the study and advancing the science and practice of obstetrics and gynaecology. It does this through postgraduate medical education and training and the publication of clinical guidelines and reports on aspects of the specialty and service provision. For more information, visit the website.

About BMS
The British Menopause Society (BMS) provides education, information and guidance to healthcare professionals specialising in all aspects of post reproductive health. The British Menopause Society is a specialist society affliated to the Royal College of Obstetricians and Gynaecologists and the Faculty of Sexual and Reproductive Healthcare.